The Effect of Foot Bath on PMS, Sleep and Quality of Life Among University Students With PMS
The Effect of Foot Bath on Premenstrual Syndrome, Sleep Quality and Quality of Life Among University Students With Premenstrual Syndrome
1 other identifier
interventional
77
1 country
2
Brief Summary
Premenstrual syndrome is a cyclical disorder characterized by physical and emotional symptoms that appear in the late luteal phase of the menstrual cycle and subside within a few days with the onset of menstruation. Non-pharmacological methods should be recommended first to women who experience PMS symptoms. For this purpose, it is planned to apply foot bath to university students with premenstrual syndrome. The study was planned as a randomized controlled single-blind study. The universe of the research will be female students studying at Ordu University Faculty of Education in the 2021-2022 academic year. In the first stage of the study, female students who are 18 years of age and older and who voluntarily agree to participate in the research will be taken without making a sample selection. Considering the possibility of data loss during the research process, it was planned to work on 39 intervention and 39 control groups, including a total of 78 women In the collection of data; Personal Information Form, Premenstrual Syndrome Scale (PMSS), Pittsburgh Sleep Quality Index (PSQI), SF-36 Quality of Life Scale will be used. PSQI and SF-36 Quality of Life Scale will be applied to students in the intervention group. The foot bath will be applied for 3 months, starting 7-10 days before the menstrual cycle, that is, in the luteal phase of the menstrual cycle. Students will be asked to fill out the Footbath Monitoring Form in order to assess whether they have taken a footbath. Those who apply foot bath at least 7 times will be included in the study. In case of less than seven students, the student will be excluded from the research and the new student who meets the criteria will be included in the research. At the end of each cycle, PMSÖ, PSQI and SF-36 will be administered to the students by the researcher. When the students in the Control Group are determined, PSQI and SF-36 will be applied by the researcher, and then PMSÖ, PSQI and SF-36 will be applied at the end of each cycle.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2021
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 6, 2021
CompletedFirst Submitted
Initial submission to the registry
November 22, 2021
CompletedFirst Posted
Study publicly available on registry
March 3, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2022
CompletedDecember 11, 2024
December 1, 2024
5 months
November 22, 2021
December 6, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Premenstrual Syndrome Scale
Students with PMS will be determined by applying the personal information form and PMSÖ to the students who accept to participate in the research. Then, PMSÖ, 1st, 2nd and 3rd cycles according to the groups. PMSÖ has nine sub-dimensions and consists of 44 questions. The lowest 44, the highest 220 points are taken from the scale. A high score indicates a greater intensity of PMS symptoms.
20 minutes
Secondary Outcomes (1)
Pittsburgh Sleep Quality Index
20 minutes
Other Outcomes (1)
SF-36 Quality of Life Scale
10 minutes
Study Arms (2)
intervention
EXPERIMENTALfoot bath intervention
control
NO INTERVENTIONfollow-up
Interventions
Students in this group will have their feet soaked in water with a temperature of 38-42 degrees for 20 minutes, half an hour before bedtime.
Eligibility Criteria
You may qualify if:
- be 18 years or older,
- Getting 111 points or more from the Premenstrual Syndrome Scale
- Being single
- Having a regular menstrual cycle for the last 6 months (every 21-35 days and no intermittent bleeding),
- Having a Body Mass Index (BMI) between 19-24.9,
- Not using cigarettes or alcohol,
- Not receiving medical treatment for PMS,
- Not receiving treatment for insomnia,
You may not qualify if:
- Having a psychiatric diagnosis
- Having a gynecological disease,
- Doing regular exercise,
- Using hormonal contraception (such as oral contraceptives and injections),
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Hüsne YÜCESOYlead
Study Sites (2)
Ordu Üniversitesi
Ordu, Altınordu, 52200, Turkey (Türkiye)
Ordu University
Ordu, Centre, 52200, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- SCREENING
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- PROF. DR.
Study Record Dates
First Submitted
November 22, 2021
First Posted
March 3, 2022
Study Start
November 6, 2021
Primary Completion
March 30, 2022
Study Completion
September 30, 2022
Last Updated
December 11, 2024
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will not share